Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
Titel:
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
Auteur:
Boni, V. Pistilli, B. Braña, I. Shapiro, G.I. Trigo, J. Moreno, V. Castellano, D. Fernández, C. Kahatt, C. Alfaro, V. Siguero, M. Zeaiter, A. Longo, F. Zaman, K. Antón, A. Paredes, A. Huidobro, G. Subbiah, V.